David McManus to Warfarin
This is a "connection" page, showing publications David McManus has written about Warfarin.
Connection Strength
0.597
-
Abu HO, Del Castillo FF, Wang W, Saczynski JS, Mehawej J, Tenes P, Tisminetzky M, Gurwitz J, Goldberg RJ, Dosa D, Kapoor A, McManus DD. The prevalence and burden of chronic kidney disease, patterns of anticoagulation prescribing, and major bleeding risk in older adults with atrial fibrillation. BMC Geriatr. 2025 Dec 28; 26(1):138.
Score: 0.222
-
Rose AJ, Goldberg R, McManus DD, Kapoor A, Wang V, Liu W, Yu H. Anticoagulant Prescribing for Non-Valvular Atrial Fibrillation in the Veterans Health Administration. J Am Heart Assoc. 2019 09 03; 8(17):e012646.
Score: 0.143
-
Alcusky M, McManus DD, Hume AL, Fisher M, Tjia J, Lapane KL. Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016. J Am Heart Assoc. 2019 05 07; 8(9):e012023.
Score: 0.140
-
Kan V, Lapane K, McManus D, Baek J, Darling C, Alcusky M. Racial disparities and trends in anticoagulant use among ambulatory care patients with atrial fibrillation and atrial flutter in the United States from 2007 to 2019. BMC Health Serv Res. 2025 Oct 03; 25(1):1300.
Score: 0.055
-
Alcusky M, Tjia J, McManus DD, Hume AL, Fisher M, Lapane KL. Comparative Safety and Effectiveness of Direct-Acting Oral Anticoagulants Versus Warfarin: a National Cohort Study of Nursing Home Residents. J Gen Intern Med. 2020 08; 35(8):2329-2337.
Score: 0.037